0000899243-21-019166.txt : 20210511 0000899243-21-019166.hdr.sgml : 20210511 20210511202916 ACCESSION NUMBER: 0000899243-21-019166 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210511 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENRIGHT PATRICK G CENTRAL INDEX KEY: 0001253886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 21913120 MAIL ADDRESS: STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tammenoms Bakker Juliet CENTRAL INDEX KEY: 0001431159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 21913119 MAIL ADDRESS: STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longitude Venture Partners III, L.P. CENTRAL INDEX KEY: 0001674099 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 21913121 BUSINESS ADDRESS: STREET 1: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-845-5700 MAIL ADDRESS: STREET 1: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longitude Capital Partners III, LLC CENTRAL INDEX KEY: 0001713663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 21913122 BUSINESS ADDRESS: STREET 1: 800 EL CAMINO, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-845-5700 MAIL ADDRESS: STREET 1: 800 EL CAMINO, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Talaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001827506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 E. JEFFERSON ST., SUITE 110B CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 502-569-1059 MAIL ADDRESS: STREET 1: 201 E. JEFFERSON ST., SUITE 110B CITY: LOUISVILLE STATE: KY ZIP: 40202 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-11 0 0001827506 Talaris Therapeutics, Inc. TALS 0001713663 Longitude Capital Partners III, LLC C/O LONGITUDE CAPITAL PARTNERS III, LLC 2740 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 0001674099 Longitude Venture Partners III, L.P. 2740 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 0001253886 ENRIGHT PATRICK G 2740 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 0001431159 Tammenoms Bakker Juliet 2740 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 Common Stock 2021-05-11 4 C 0 2985775 A 2985775 I By Longitude Venture Partners III, L.P. Common Stock 2021-05-11 4 P 0 235000 17.00 A 3220775 I By Longitude Venture Partners III, L.P. Series A Preferred Stock 2021-05-11 4 C 0 1308410 0.00 D Common Stock 1308410 0 I By Longitude Venture Partners III, L.P. Series A-1 Preferred Stock 2021-05-11 4 C 0 1271027 0.00 D Common Stock 1271027 0 I By Longitude Venture Partners III, L.P. Series B Preferred Stock 2021-05-11 4 C 0 406338 0.00 D Common Stock 406338 0 I By Longitude Venture Partners III, L.P. Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date. These shares are held by Longitude Venture Partners III, L.P ("LVP III"). Longitude Capital Partners III, LLC ("LCP III") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. On May 11, 2021, LVP III purchased 235,000 shares of Common Stock of the Issuer at a price of $17.00 per share pursuant to an underwritten public offering. /s/ Patrick G. Enright, individually, and as Managing Member of Longitude Capital Partners III, LLC and as Managing Member of Longitude Capital Partners III, LLC., General Partner of Longitude Venture Partners III, L.P. 2021-05-11 /s/ Juliet Tammenoms Bakker 2021-05-11